Yuyu Pharma launches three 'Kozal' products to relieve nasal congestion and rhinitis, targeting the nasal care market
Predicted impact: Low
Three nasal care product launches; small new product line with no size given.
000220 · KOSPI · ₩000220 · 유유제약
Predicted impact: Low
Three nasal care product launches; small new product line with no size given.
Predicted impact: Low
Formulation platform tech already reported in the last 14 days; no financial impact stated.
Predicted impact: Low
Multi-dosage tablet and capsule technology development; small pipeline news for a small pharma.
Predicted impact: Low
Platform technology and trademark registration for a small pharma company; no revenue impact disclosed.
Also known as: Yuyu Pharma / 유유제약 / 000220 / KRX:000220
Source: KRX statistical information